peptide-based immune system response modifiers in prescription pharmaceutical compositions for the modulation of immune or autoimmune responses in the prophylaxis or treatment of conditions in the nature of insulin dependent, juvenile-onset diabetes, multiple sclerosis, pemphigus vulgaris, Grave's disease, myasthenia gravis, systemic lupus erythematosus, rheumatoid arthritis, Hashimoto's thyroiditis, asthma, pathogenic infections, cancer, and allogeneic tissue graft rejection

'allogen':59 'arthriti':50 'asthma':54 'autoimmun':18 'base':3 'cancer':57 'composit':11 'condit':26 'depend':32 'diabet':36 'diseas':43 'erythematosus':48 'graft':61 'grave':41 'gravi':45 'hashimoto':51 'immun':4,16 'infect':56 'insulin':31 'juvenil':34 'juvenile-onset':33 'lupus':47 'modifi':7 'modul':14 'multipl':37 'myasthenia':44 'natur':29 'onset':35 'pathogen':55 'pemphigus':39 'peptid':2 'peptide-bas':1 'pharmaceut':10 'prescript':9 'prophylaxi':22 'reject':62 'respons':6,19 'rheumatoid':49 'sclerosi':38 'system':5,46 'thyroid':53 'tissu':60 'treatment':24 'vulgari':40

PEPTIMER

Owners

Goods & Services